1. mokakaippnxxtsz7
2. keiththewolf94
3. coskot
4. phmolter
5. mjones5944
1.phmolter 02/05/2018
Stifel Nicolaus cuts PT to $20 from $25
2.coskot 02/05/2018
BOUNCE WHEN THE MARKET RECOVERS
3.keiththewolf94 09/28/2018
Receives FDA orphan drug designation for Relacorilant
4.keiththewolf94 02/05/2018
hoping $16 holds
5.mokakaippnxxtsz7 02/26/2018
Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial
6.mjones5944 02/05/2018
ouch! {Image}
7.mjones5944 02/02/2018
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
8.keiththewolf94 02/22/2018
Reports Relacorilant Phase 2 Trial interim results
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW